Overview of Pharma Shanghai (301230.SZ)
- Last trading session (24‑hour period ending 10:07 AM Central Europe, Thursday 22 Oct 2026): No change in price (0 %).
- Current trading price: CNY 35.34 per share on major exchanges.
- Market capitalization: CNY 6.4 billion.
- Trading volume in the last 24 hours: Approximately CNY 1.1 billion.
- Shares outstanding: 175.7 million.
- Performance since end of last month: Down 7.88 %.
- Simple moving average (SMA) over 200 days: CNY 30.69.
- 52‑week range:
- High: CNY 52.28 (14 Jan 2026)
- Low: CNY 22.23 (17 Dec 2025)
Comparative Performance of Related Stocks (Last 24 hours)
| Symbol | Current Price (CNY) | Market Capitalization (CNY) | P/E Ratio | 24‑hour Change |
|---|---|---|---|---|
| C*core (688262.SS) | 23.78 | 7.7 billion | – | 0 % |
| Guangzhou Ruili Kormee Aut (001285.SZ) | 28.81 | 7.7 billion | 19.38 | 0 % |
| Baosheng Science And Tech (600973.SS) | 5.57 | 7.6 billion | 388.19 | 0 % |
| Zhejiang Ev‑Tech (301607.SZ) | 31.4 | 7.7 billion | – | 0 % |
| Guizhou Zhongyida (600610.SS) | 6.95 | 1.1 billion | 165.79 | 0 % |
Market Context
- Pharma Shanghai’s price movement remained flat during the referenced 24‑hour window, reflecting a stable trading environment for the day.
- Overall liquidity is moderate, with a trading volume of CNY 1.1 billion against a market cap of CNY 6.4 billion.
- Relative valuation: The 52‑week high and low indicate a range that has not been breached recently, suggesting the stock has not experienced significant volatility in the short term.
- Peer comparison: The related stocks listed above show similar stability in their 24‑hour performance, with no price changes reported. Their market capitalizations vary from CNY 1.1 billion to CNY 7.7 billion, and their price‑to‑earnings ratios differ widely, indicating diverse valuation levels across the sector.
Key Takeaways
- Pharma Shanghai is trading at a price close to its 200‑day SMA, indicating a potential support level.
- The flat 24‑hour price action aligns with the broader stability observed in related stocks.
- Investors should monitor the upcoming earnings reports and macroeconomic data for any shifts in valuation or trading activity.
